• Thumbnail for Levodopa
    Levodopa, also known as L-DOPA and sold under many brand names, is a dopaminergic medication which is used in the treatment of Parkinson's disease and...
    32 KB (2,836 words) - 10:41, 30 November 2024
  • Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. It is primarily used to...
    18 KB (1,524 words) - 06:31, 22 December 2024
  • Thumbnail for L-DOPA
    l-DOPA, also known as l-3,4-dihydroxyphenylalanine and used medically as levodopa, is made and used as part of the normal biology of some plants and animals...
    16 KB (1,607 words) - 18:03, 18 December 2024
  • Thumbnail for Carbidopa/levodopa/entacapone
    Carbidopa/levodopa/entacapone, sold under the brand name Stalevo among others, is a dopaminergic fixed-dose combination medication that contains carbidopa...
    10 KB (734 words) - 03:29, 28 September 2024
  • Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease...
    4 KB (89 words) - 03:31, 28 September 2024
  • Levodopa-induced dyskinesia (LID) is a form of dyskinesia associated with levodopa (l-DOPA), used to treat Parkinson's disease. It often involves hyperkinetic...
    15 KB (1,642 words) - 20:30, 6 November 2024
  • Thumbnail for Parkinson's disease
    confirmed by two of the following criteria: responsiveness to levodopa, resting tremor, levodopa-induced dyskinesia, or with dopamine transporter single-proton...
    146 KB (15,983 words) - 19:14, 21 December 2024
  • Thumbnail for Entacapone
    treatment of Parkinson's disease. Entacapone together with levodopa and carbidopa allows levodopa to have a longer effect in the brain and reduces Parkinson's...
    17 KB (1,519 words) - 09:29, 8 October 2024
  • Thumbnail for Carbidopa
    peripheral metabolism of levodopa. This property is significant in that it allows a greater proportion of administered levodopa to cross the blood–brain...
    11 KB (1,122 words) - 23:12, 28 October 2024
  • of 2017.[relevant?] Levodopa-induced dyskinesia (LID) is evident in patients with Parkinson's disease who have been on levodopa (L‑DOPA) for prolonged...
    11 KB (1,147 words) - 07:03, 26 November 2024
  • Parkinson's. The main families of drugs useful for treating motor symptoms are levodopa, dopamine agonists, and MAO-B inhibitors. The most commonly used treatment...
    73 KB (8,626 words) - 01:57, 1 December 2024
  • Thumbnail for Catechol-O-methyltransferase inhibitor
    It also methylates levodopa. COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino...
    10 KB (1,107 words) - 09:34, 8 October 2024
  • Thumbnail for Benserazide
    used in the management of Parkinson's disease in combination with L-DOPA (levodopa) as co-beneldopa (BAN), under the brand names Madopar in the UK and Prolopa...
    8 KB (460 words) - 06:40, 18 September 2024
  • prolonged use of levodopa, the delusions occupy almost all of a patient's attention. In experimental studies, when the concentration of levodopa decreases,...
    22 KB (2,599 words) - 05:57, 22 November 2024
  • Thumbnail for Thalamotomy
    the uncontrolled movements that can occur in patients taking the drug levodopa for a long time. Thalamotomy can be performed in an invasive or noninvasive...
    11 KB (1,384 words) - 14:40, 24 October 2024
  • Thumbnail for Catechol-O-methyltransferase
    substrates of COMT. Levodopa, a precursor of catecholamines, is an important substrate of COMT. COMT inhibitors, like entacapone, save levodopa from COMT and...
    29 KB (3,236 words) - 00:14, 10 July 2024
  • Thumbnail for Foscarbidopa/foslevodopa
    aromatic amino acid and prodrug for levodopa that was developed by AbbVie. Its structure is identical to carbidopa/levodopa except for the replacement of a...
    9 KB (622 words) - 22:15, 18 December 2024
  • XP-21279 is a sustained-release levodopa (L-DOPA) prodrug and hence a dopamine precursor and non-selective dopamine receptor agonist which was under development...
    7 KB (497 words) - 12:28, 28 September 2024
  • Thumbnail for Progressive supranuclear palsy
    the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases. PSP affects about six people...
    41 KB (4,459 words) - 22:39, 21 December 2024
  • Thumbnail for Melevodopa/carbidopa
    taken orally in the form of tablets. Levodopa/carbidopa Foscarbidopa/foslevodopa Levodopa/carbidopa/entacapone Levodopa/benserazide "Melevodopa: Uses, Interactions...
    5 KB (211 words) - 14:40, 27 September 2024
  • Thumbnail for Foslevodopa
    Foslevodopa is a medication which acts as a prodrug for levodopa, originally invented in the 1980s but not developed for medical use at that time. It is...
    3 KB (186 words) - 07:47, 18 October 2024
  • Thumbnail for Opicapone
    brand name Ongentys, is a medication which is administered together with levodopa in people with Parkinson's disease. Opicapone is a catechol-O-methyltransferase...
    33 KB (1,828 words) - 14:27, 14 December 2024
  • Thumbnail for Dihydroergocryptine
    reduced risk for motor complications in Parkinson patients relative to levodopa. DHEC, like other dopamine agonists, aims to mimic the endogenous neurotransmitter...
    16 KB (1,532 words) - 03:15, 21 December 2024
  • fluphenazine, olanzapine), carbamazepine, chloroquine, cisplatin, diazoxide, levodopa, lithium, metoclopramide, lurasidone, domperidone, nifedipine, pemoline...
    10 KB (883 words) - 01:03, 16 September 2024
  • Thumbnail for Amantadine
    extended-release formulation was approved for use in the treatment of levodopa-induced dyskinesia. Amantadine was initially developed to prevent influenza...
    62 KB (6,117 words) - 20:18, 10 December 2024
  • Dopa or DOPA may refer to: Dihydroxyphenylalanine (DOPA) L-DOPA (levodopa), used in the treatment of Parkinson's disease D-DOPA, an enantiomer of L-DOPA...
    497 bytes (90 words) - 03:06, 21 May 2020
  • Thumbnail for Droxidopa
    α- and β-adrenergic receptors. Unlike norepinephrine, but similarly to levodopa (L-DOPA), droxidopa is capable of crossing the protective blood–brain barrier...
    16 KB (1,316 words) - 07:09, 9 December 2024
  • Thumbnail for Dopamine
    substantia nigra. Its metabolic precursor L-DOPA can be manufactured; Levodopa, a pure form of L-DOPA, is the most widely used treatment for Parkinson's...
    139 KB (14,295 words) - 21:14, 14 December 2024
  • Benzatropine N04AC30 Etybenzatropine N04BA01 Levodopa N04BA02 Levodopa and decarboxylase inhibitor N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor...
    2 KB (262 words) - 15:38, 25 January 2024
  • Thumbnail for Substantia nigra
    fields of neuropharmacology and toxicology. Various compounds such as levodopa and MPTP are used in the treatment and study of Parkinson's disease, and...
    47 KB (5,466 words) - 14:37, 9 December 2024